TNF and juvenile idiopathic arthritis: Although anti-TNF-α treatments have proven efficacious in the treatment of JIA and are included in treatment guidelines,35 the increase in costs and the lack of long-term cost-effectiveness data contribute to reasons why they are usually not prescribed earliest in the disease course.14